Plymouth Meeting-based Inovio Pharmaceuticals is currently in talks with large drugmakers to secure prompt delivery of its coronavirus vaccine if the development is successful…

Inovio Pharmaceuticals, Inc. has entered into a partnership with the AIDS Malignancy Consortium to evaluate VGX-3100 as a potential therapy for HIV-positive adult…

Plymouth Meeting’s Inovio Pharmaceuticals received good news from the preliminary results of its expanded stage phase I study of EBOV-001, the company’s…

Popular Mechanics, a magazine that serves as the country’s leading voice in technology, has named the progress made by Inovio Pharmaceuticals on its Zika…

Inovio Pharmaceuticals has received a green light from the Food and Drug Administration to start human testing of its experimental vaccine for the Zika virus…

Plymouth Meeting’s Inovio Pharmaceuticals has announced that testing of its synthetic vaccine for the Zika virus induced robust antibody and T-cell responses in…

Plymouth Meeting-based Inovio Pharmaceuticals Inc. recently reported positive results from early-stage testing of its experimental Ebola vaccine, writes John George of the Philadelphia…